BioSpace News Archive

Surgical Gown Market: Rising number of surgeries all across the world is attributing to the market revenue growth

The global surgical gown market is riding on the back of the rise in surgeries all across the world due to rise in prevalence of various chronic diseases.

July 31, 2020
·
4 min read
Hospital Furniture Market: Coronavirus Pandemic Fuels Demand for Easy-to-Manage Quarantine Beds

According to the report, the global hospital furniture market was valued at US$ 9.5 Bn in 2019 and is projected to expand at a high CAGR during the forecast period.

July 31, 2020
·
7 min read
Brain Navi Develops New Robot Performing Nasal Swab Tests to Prevent Cross Infections

Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies.

July 31, 2020
·
2 min read
Multiplex Biomarker Imaging Market Key Players are Increasingly Focused on Finding Advanced Biomarker Techniques

In order to detect structural and functional proteins in cells of tissue samples, multiplexed staining technique is a common approach utilized.

July 31, 2020
·
6 min read
Business

111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020

111, Inc., a Company dedicated to digitally connecting patients with drugs and healthcare services in China, announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens on Thursday, August 20, 2020.

July 31, 2020
·
2 min read
Business

Hillrom Reports Strong Third Quarter 2020 Financial Results

Hillrom (NYSE: HRC) today announced financial results for its fiscal third quarter ended June 30, 2020 and provided commentary on current business trends and outlook.

July 31, 2020
·
13 min read
Business

Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that it will report second quarter ended June 30, 2020 financial results on Friday, August 7, 2020.

July 31, 2020
·
2 min read
FDA

Xencor Earns Milestone Payment from MorphoSys for FDA Approval of Monjuvi® (tafasitamab-cxix) in the United States

Monjuvi is a new treatment in combination with lenalidomide for adult patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL)

July 31, 2020
·
5 min read
FDA

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

The U.S. Food and Drug Administration approved Epidiolex [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex in patients one year of age and older.

July 31, 2020
·
4 min read
FDA

Tuberous Sclerosis Alliance Lauds FDA Approval of Epidiolex® to Treat Seizures in People with Tuberous Sclerosis Complex

, the Tuberous Sclerosis Alliance lauds the U.S. Food and Drug Administration’s approval of Epidiolex® oral solution to treat seizures in people one year of age and older who have tuberous sclerosis complex.

July 31, 2020
·
2 min read